Navigation Links
Genetic-Engineered Cows Resist Mad Cow Disease

Scientists from U.S. and Japan have reported in the journal Nature Biotechnology yesterday about the genetic engineering techniques to produce the first //cattle that may be biologically incapable of getting mad cow disease.

They hope the cattle can be the source of herds that can provide dairy products, gelatin and other products free of the brain-destroying disease, also known as bovine spongiform encephalopathy or BSE. The animals, which lack a gene that is crucial to the disease's progression, were not designed for use as food. They were created so that human pharmaceuticals can be made in their blood without the danger that those products might get contaminated with the infectious agent that causes mad cow.

Writing in the journal, the scientists said their cattle were healthy at the age of 20 months, and sperm from the males made normal embryos that were used to impregnate cows, although it is not certain yet that they could breed normally. They added that the cattle lack the nervous system prions, a type of protein, that cause BSE and other related diseases such as scrapie in sheep and Creutzfeldt-Jakob disease, known as CJD, in humans.

Yoshimi Kuroiwa of Kirin Brewery Company in Tokyo, Japan and colleagues made the cattle, known as knockouts because a specific gene has been "knocked" out of them, using a method they call gene targeting. "By knocking out the prion protein gene and producing healthy calves, our team has successfully demonstrated that normal cellular prion protein is not necessary for the normal development and survival of cattle. The cows are now nearly 2 years old and are completely healthy," said James Robl of Hematech, a South Dakota subsidiary of Kirin.

Mr Robl, an expert in cloning technology, said: "We anticipate that prion protein-free cows will be useful models to study prion disease processes in both animals and humans."
SRI
'"/>




Page: 1

Related medicine news :

1. Link between birth weight and Insulin Resistance
2. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
3. Easier Methods Required to Screen Insulin Resistance
4. Easier Methods Required to Screen Insulin Resistance
5. Insulin Resistance Linked To Difference In Gender
6. Hope for Chemo-Resistant Leukemia Patients
7. Adopting Easier Methods To Screen Insulin Resistance
8. Drug Resistance Questioned in Patients With Chronic Sinusitis
9. Understanding Insulin Resistance
10. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: